Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Diabetes

  Free Subscription


12.01.2026

2 Am J Epidemiol
4 Am J Manag Care
1 Ann Intern Med
1 Atherosclerosis
1 Biochem Biophys Res Commun
2 BMC Ophthalmol
2 BMC Pediatr
1 BMJ
7 Diabet Med
1 Diabetes
3 Diabetes Care
14 Diabetes Obes Metab
6 Diabetologia
1 JAMA
2 Kidney Int
1 Med Care
1 N Engl J Med
1 Nat Genet
6 PLoS One
1 Proc Natl Acad Sci U S A


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Epidemiol

  1. RUSSO M, Sreedhara SK, Smith J, Davis SE, et al
    Electronic health record-enhanced signal detection using tree-based scan statistic methods.
    Am J Epidemiol. 2026;195:178-187.
    PubMed         Abstract available

  2. POWER GM, Palmer T, Warrington N, Heron J, et al
    A structural mean modelling Mendelian randomization approach to investigate the lifecourse effect of adiposity: applied and methodological considerations.
    Am J Epidemiol. 2025 Feb 17:kwaf029. doi: 10.1093.
    PubMed         Abstract available


    Am J Manag Care

  3. PATEL BV, Wang SM, Messer LH, Pinsker JE, et al
    HEDIS glycemic goal achieved using control-IQ Technology.
    Am J Manag Care. 2025;31:e357-e363.
    PubMed         Abstract available

  4. SHOAIB N, Azhar N, Shoaib M
    GLP-1 receptor agonists: trend, necessity, or blessing?
    Am J Manag Care. 2025;31.
    PubMed         Abstract available

  5. PANGRACE M, Albright J, Basta S, Bratcher T, et al
    Exploratory study of selected stakeholder insights into continuous glucose monitoring in T2D with risk-sharing agreements.
    Am J Manag Care. 2025;31.
    PubMed         Abstract available

  6. SHENOY DA, Cummins L, Kaplan S, Zullig LL, et al
    Interventions addressing cost-related medication nonadherence in diabetes: a scoping review.
    Am J Manag Care. 2025;31.
    PubMed         Abstract available


    Ann Intern Med

  7. KRISTENSEN FPB, Christensen DH, Callaghan BC, Nielsen JS, et al
    Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists on Diabetic Foot Disease : An Emulated Target Trial.
    Ann Intern Med. 2026 Jan 6. doi: 10.7326/ANNALS-25-01262.
    PubMed         Abstract available


    Atherosclerosis

  8. MOON S, Hong S, Han K, Park CY, et al
    Effects of cilostazol on the prognosis of lower extremity peripheral arterial disease in patients with diabetes mellitus in Korea: A nationwide population-based study.
    Atherosclerosis. 2025;413:120634.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  9. ZHANG M, Bi H, Guo D
    Advances in study of endoplasmic reticulum stress in ophthalmic diseases: an overview.
    Biochem Biophys Res Commun. 2026;797:153182.
    PubMed         Abstract available


    BMC Ophthalmol

  10. MA Z, Yu F, Li H, Liu Y, et al
    Divergent nasal-temporal changes in superficial vascular density as early biomarkers of diabetic retinopathy.
    BMC Ophthalmol. 2026;26:11.
    PubMed         Abstract available

  11. SADEGHI R, Abdol Homayuni MR, Fateh A, Ebrahimzadeh N, et al
    The gut-eye axis: microbiota and their role in diabetic retinopathy: a systematic review and meta-analysis.
    BMC Ophthalmol. 2026;26:7.
    PubMed         Abstract available


    BMC Pediatr

  12. DOKHAN-VURAL S, Kahlert CR, Roduit C, Heldt K, et al
    Health-related quality of life, glycaemic control, lifestyle characteristics and SARS-CoV-2 prevalence in children with type 1 diabetes during the COVID-19 pandemic: results of a longitudinal, prospective single-centre Swiss study.
    BMC Pediatr. 2026 Jan 6. doi: 10.1186/s12887-025-06375.
    PubMed         Abstract available

  13. MORADI A, Norouzi M, Farkhani EM
    Impact of gestational weight gain on adverse pregnancy outcomes in women with gestational diabetes: a retrospective cohort study.
    BMC Pediatr. 2026;26:13.
    PubMed         Abstract available


    BMJ

  14. ALLOTEY J, Coomar D, Ensor J, Ruiz-Calvo G, et al
    Effects of lifestyle interventions in pregnancy on gestational diabetes: individual participant data and network meta-analysis.
    BMJ. 2026;392:e084159.
    PubMed         Abstract available


    Diabet Med

  15. HAUGVIK S, Hennekes MHCL, de Wit M, Toschi E, et al
    Can the Diabetes Eating Problem Survey-Revised (DEPS-R) reliably identify eating disorder diagnosis in women with type 1 diabetes?
    Diabet Med. 2026 Jan 8:e70207. doi: 10.1111/dme.70207.
    PubMed         Abstract available

  16. LEE VY, Donges K, Beech A, Makris A, et al
    Type 2 diabetes after gestational diabetes, a cross-sectional study-DIVINE-NSW.
    Diabet Med. 2026 Jan 9:e70155. doi: 10.1111/dme.70155.
    PubMed         Abstract available

  17. DAVIS TME, Davis WA
    Incidence and associates of aortic valve replacement in people with or without type 2 diabetes: The Fremantle diabetes study phase II.
    Diabet Med. 2026 Jan 5:e70211. doi: 10.1111/dme.70211.
    PubMed         Abstract available

  18. SUN J, Miao G, Meng C
    Expanding insights on automated insulin delivery and physical activity in type 1 diabetes.
    Diabet Med. 2026 Jan 6:e70213. doi: 10.1111/dme.70213.
    PubMed        

  19. ZIEGLER J, Neu A, Ehehalt S, Schweizer R, et al
    Age-specific incidence and prevalence of childhood type 1 diabetes: Development over four decades in Southwest Germany.
    Diabet Med. 2026 Jan 6:e70215. doi: 10.1111/dme.70215.
    PubMed         Abstract available

  20. ZHU W, Wang H, Xu T, Zhang S, et al
    Burden of type 2 diabetes in Asia-Pacific regions, 1990-2021: GBD 2021 analysis with forecast to 2050.
    Diabet Med. 2026 Jan 6:e70216. doi: 10.1111/dme.70216.
    PubMed         Abstract available

  21. SOHOLM U, Thuraisingam S, Holmes-Truscott E, de Zoysa N, et al
    Changes in HbA1c and diabetes-specific quality of life following structured type 1 diabetes education: Exploratory latent profile analysis of outcomes in the DAFNEplus trial.
    Diabet Med. 2026 Jan 8:e70203. doi: 10.1111/dme.70203.
    PubMed         Abstract available


    Diabetes

  22. KONTIDOU E, Collado A, Humoud R, Manickam K, et al
    Long Duration of Type 2 Diabetes Drives Erythrocyte-Induced Vascular Endothelial Dysfunction: A Link to miRNA-210-3p.
    Diabetes. 2026 Jan 9:db250463. doi: 10.2337/db25-0463.
    PubMed         Abstract available


    Diabetes Care

  23. HE JH, Wang D, Rooney MR, Wallace AS, et al
    Defining Clinically Interpretable Glycemic Profiles Using Continuous Glucose Monitoring in Type 2 Diabetes.
    Diabetes Care. 2026 Jan 9:dc252633. doi: 10.2337/dc25-2633.
    PubMed        

  24. FENG Q, Albalak G, Ao L, Xiao Q, et al
    Associations of Moderate-to-Vigorous Physical Activity Timing With Type 2 Diabetes Incidence in UK Biobank and Prevalent Glycemic Measures in NHANES.
    Diabetes Care. 2026 Jan 9:dc252095. doi: 10.2337/dc25-2095.
    PubMed         Abstract available

  25. BRODSGAARD RB, Mizrak HI, Brock B, Rossing P, et al
    Vitamin B12 and Neuropathy in Type 1 Diabetes.
    Diabetes Care. 2026 Jan 9:dc252168. doi: 10.2337/dc25-2168.
    PubMed        


    Diabetes Obes Metab

  26. RIVELINE JP, Renard E, Aleppo G, Bode BW, et al
    Psychosocial outcomes among adults with type 1 diabetes using a tubeless automated insulin delivery system compared with sensor augmented pump therapy: A randomised, parallel-group clinical trial sub-study.
    Diabetes Obes Metab. 2026 Jan 8. doi: 10.1111/dom.70416.
    PubMed         Abstract available

  27. TAN X, Liang Y, Xie L, Harton J, et al
    Comparison of cardiovascular outcomes between once-weekly semaglutide and dulaglutide in adults with type 2 diabetes and established atherosclerotic cardiovascular disease in the United States.
    Diabetes Obes Metab. 2026 Jan 8. doi: 10.1111/dom.70440.
    PubMed         Abstract available

  28. ZAWADKA M, Taguiam E, Le ML, Sanjanwala R, et al
    Sex differences in trial representation and the cardiovascular effectiveness of newer glucose-lowering agents in patients with and without type 2 diabetes: A systematic review and meta-analysis of cardiovascular outcome trials.
    Diabetes Obes Metab. 2026 Jan 8. doi: 10.1111/dom.70411.
    PubMed         Abstract available

  29. OH R, Kim S, Cho SH, Kim JY, et al
    Elevated triglyceride-glucose index is associated with increased risk of chronic kidney disease and end-stage renal disease in type 1 diabetes: Nationwide cohort study.
    Diabetes Obes Metab. 2026 Jan 7. doi: 10.1111/dom.70455.
    PubMed         Abstract available

  30. HERMANNS N, Kittel P, Cerletti P, Kulzer B, et al
    Independent associations of mental health and diabetes complications with health-related quality of life: Evidence from a cross-sectional study.
    Diabetes Obes Metab. 2026 Jan 7. doi: 10.1111/dom.70434.
    PubMed         Abstract available

  31. TONG X, Zhang Y, Zhang L, Zhang L, et al
    Once-weekly insulin icodec versus once-daily insulin degludec for type 2 diabetes in China: A cost-utility and budget impact analysis.
    Diabetes Obes Metab. 2026 Jan 6. doi: 10.1111/dom.70435.
    PubMed         Abstract available

  32. KISHIMORI T, Kato T, Iwasaki Y, Shimada T, et al
    Oral semaglutide and survival in heart failure with preserved ejection fraction and type 2 diabetes.
    Diabetes Obes Metab. 2026 Jan 5. doi: 10.1111/dom.70433.
    PubMed         Abstract available

  33. CHEN L, Zhang Q, Duan B, Wu X, et al
    Effects of age and disease duration on the glycaemic outcomes and safety of insulin glargine 300 U/mL in people with type 2 diabetes in China: A post-hoc analysis of the INITIATION study.
    Diabetes Obes Metab. 2026 Jan 5. doi: 10.1111/dom.70420.
    PubMed         Abstract available

  34. KABYTAEV K, Maddaloni E, Ferm ML, Redondo MJ, et al
    C-peptide as an important biomarker in diabetes management: The need for standardization of its measurement.
    Diabetes Obes Metab. 2026 Jan 5. doi: 10.1111/dom.70447.
    PubMed        

  35. TAJIMA T, Kaga H, Ito N, Kogai T, et al
    Dual action of imeglimin on insulin secretion and sensitivity in type 2 diabetes.
    Diabetes Obes Metab. 2026 Jan 5. doi: 10.1111/dom.70449.
    PubMed         Abstract available

  36. YEO YH, San BJ, Lim GK, Tan MC, et al
    Increasing cardiovascular mortality in young adults with diabetes mellitus as a contributing cause in the United States.
    Diabetes Obes Metab. 2026 Jan 5. doi: 10.1111/dom.70441.
    PubMed         Abstract available

  37. MARIGLIANO M, Mozzillo E, Romanelli R, Passanisi S, et al
    Higher post-prandial glucose excursions in youth with type 1 diabetes and celiac disease: Time to change the bolus?
    Diabetes Obes Metab. 2026 Jan 8. doi: 10.1111/dom.70430.
    PubMed        

  38. GIUGLIANO D, Longo M, Di Martino N, Scappaticcio L, et al
    GLP1-1RAs improve walking distance and reduce amputation in people with type 2 diabetes and peripheral artery disease: A systematic review and meta-analysis of randomised controlled trials and cohort studies.
    Diabetes Obes Metab. 2026 Jan 8. doi: 10.1111/dom.70454.
    PubMed         Abstract available

  39. SUGIMOTO T, Omura T, Araki A, Haneda C, et al
    Long-term effects of a multidomain intervention on cognitive function and metabolic control in older adults with type 2 diabetes and mild cognitive impairment: A 42-month follow-up of the J-MIND-Diabetes study.
    Diabetes Obes Metab. 2026 Jan 8. doi: 10.1111/dom.70431.
    PubMed         Abstract available


    Diabetologia

  40. THOMSON RL, Martin G, McGorm KJ, Spelman T, et al
    Perceived stress in mothers of children with and without islet and coeliac autoimmunity in the ENDIA study.
    Diabetologia. 2026;69:343-349.
    PubMed         Abstract available

  41. SMEDEGAARD S, Rittig N, Ovesen PG, Suder LB, et al
    Once-daily supplementation with pre-meal whey protein lowers breakfast postprandial glucose levels in women with GDM throughout the third trimester: a randomised, controlled, clinical trial.
    Diabetologia. 2026;69:350-363.
    PubMed         Abstract available

  42. PREFONTAINE C, Pipella J, Rampazzo Morelli N, Chen YC, et al
    Insulin production is sustained during DNA damage-mediated senescence in adult human beta cells.
    Diabetologia. 2026;69:421-435.
    PubMed         Abstract available

  43. NAIR AK, Barkho K, Cheranda KP, Traurig M, et al
    Modelling the effects of human SUR1 R1420H variation on insulin secretory function using isogenic iPSC-derived pancreatic islets.
    Diabetologia. 2026;69:399-420.
    PubMed         Abstract available

  44. JOING I, Marais G, Huchez A, Lespagnol E, et al
    How adolescents with type 1 diabetes experience physical education in middle school: a qualitative study.
    Diabetologia. 2026 Jan 7. doi: 10.1007/s00125-025-06648.
    PubMed         Abstract available

  45. WESTHOLM E, Karagiannopoulos A, Nielsen BU, Shaw JAM, et al
    Dynamic changes in circulating microRNAs during oral glucose tolerance testing support their potential as diagnostic and monitoring biomarkers in cystic fibrosis-related diabetes.
    Diabetologia. 2026 Jan 7. doi: 10.1007/s00125-025-06645.
    PubMed         Abstract available


    JAMA

  46. MAYA J, Pant D, Fu Y, James K, et al
    Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation.
    JAMA. 2025 Nov 24:e2520951. doi: 10.1001/jama.2025.20951.
    PubMed         Abstract available


    Kidney Int

  47. PRUIJM M, Belmar N, Bjornstad P, Cherney DZI, et al
    REMODELing mechanistic trials for kidney disease: a multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide.
    Kidney Int. 2026;109:6-16.
    PubMed         Abstract available

  48. SCHUG AP, Ly LT, Eckardt KU, Balzer MS, et al
    The Case | The sweet twirl-chorea as a diabetic complication: an elderly patient with CKD, hyperglycemia, and chorea.
    Kidney Int. 2026;109:235-236.
    PubMed        


    Med Care

  49. NELSON LA, Bergner EM, Adler A, Yoon C, et al
    Development and Value of a Centralized Text Message-based Tracking and Support Program for the PRECIDENTD Study.
    Med Care. 2026;64.
    PubMed         Abstract available


    N Engl J Med

  50. BOHULA EA, Marston NA, Bhatia AK, De Ferrari GM, et al
    Evolocumab in Patients without a Previous Myocardial Infarction or Stroke.
    N Engl J Med. 2025 Nov 8. doi: 10.1056/NEJMoa2514428.
    PubMed         Abstract available


    Nat Genet

  51. SOREMEKUN O, Park YC, Tutino M, Arruda AL, et al
    Linking the plasma proteome to genetics in individuals from continental Africa provides insights into type 2 diabetes pathogenesis.
    Nat Genet. 2026 Jan 8. doi: 10.1038/s41588-025-02421.
    PubMed         Abstract available


    PLoS One

  52. AMARE F, Kiflu A, Taddese A
    Impact of exercise sequence in concurrent training on insulin resistance, glycemic control, and blood pressure in Type 2 diabetes.
    PLoS One. 2026;21:e0340587.
    PubMed         Abstract available

  53. NONG VD, Nguyen DQ, Do TT, Giang Tran TH, et al
    Identification of stable internal reference genes for expression analysis in the liver and pancreas of diabetic mouse (Mus musculus L.) models under physiological, pathological and treatment conditions.
    PLoS One. 2026;21:e0338403.
    PubMed         Abstract available

  54. ELKENAWY EM, Khodadadi N, Gaber KS, Khodadadi E, et al
    Automated retinal disease classification using deep learning and AlexNet with statistical models analysis.
    PLoS One. 2026;21:e0338415.
    PubMed         Abstract available

  55. HERRAIZ-ADILLO A, Radholm K, Iredahl F, Carlhall CJ, et al
    Validity of the International Fitness Scale (IFIS) and its associations with cardiometabolic health and body composition in adults with type 2 diabetes: A cross-sectional study.
    PLoS One. 2026;21:e0339364.
    PubMed         Abstract available


  56. Expression of Concern: Quality of information in gestational diabetes mellitus videos on TikTok: Cross-sectional study.
    PLoS One. 2026;21:e0340234.
    PubMed        

  57. WESTALL SJ, Watmough S, Narayanan RP, Irving G, et al
    Feasibility of glycated haemoglobin target-setting in adults with diabetes: A mixed-methods study.
    PLoS One. 2026;21:e0317162.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  58. CHEN C, Zhu L, Li W, Jiang Y, et al
    Hyperglycemia promotes SIRT3-mediated deacetylation of SARM1 to exacerbate diabetic peripheral neuropathy in mice.
    Proc Natl Acad Sci U S A. 2026;123:e2517110123.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.